News & Updates

Degarelix tied to BMD decrease in prostate cancer

07 Dec 2022

Treatment with degarelix results in a substantial reduction in bone mineral density (BMD) and an increase in bone turnover markers, reports a study.

Degarelix tied to BMD decrease in prostate cancer

07 Dec 2022

PCSK9 inhibitors safe, effective in Asian patients, but expensive to use

07 Dec 2022 by

PCSK9 inhibitors alirocumab and evolocumab are not only safe and well tolerated but also efficacious in Asian patients, results of a real-world study in Singapore have shown. However, about a third of patients stopped using these medications due to their high costs.

PCSK9 inhibitors safe, effective in Asian patients, but expensive to use

07 Dec 2022

Exposure to air pollution ups risk of atopic dermatitis

07 Dec 2022

Long-term exposure to air pollutants, including gases and particulate matter, may increase the risk of developing atopic dermatitis (AD), according to a recent study.

Exposure to air pollution ups risk of atopic dermatitis

07 Dec 2022

Singapore’s youth endure high rates of bullying

07 Dec 2022 by

Peer victimization, or bullying, appears to be highly prevalent among youth, according to a recent Singapore study. In turn, bullying aggravates depressive symptoms and worsens quality of life.

Singapore’s youth endure high rates of bullying

07 Dec 2022

Infants with lower birthweight may have poorer cardiovascular health in midlife

07 Dec 2022

Lower birthweight appears to carry an increased future risk of developing myocardial infarction (MI) and unhealthy left ventricular (LV) phenotypes, a study has found.

Infants with lower birthweight may have poorer cardiovascular health in midlife

07 Dec 2022

Cyclosporin may increase malignancy risk in psoriasis

07 Dec 2022

In psoriasis patients, treatment with cyclosporin may increase the risk of malignancy without nonmelanoma skin cancer, a recent study has found. Biologic or phototherapy have no such impact.

Cyclosporin may increase malignancy risk in psoriasis

07 Dec 2022

DUET OLE supports long-term nephroprotection of sparsentan for FSGS patients

07 Dec 2022 by

Results from the open-label extension (OLE) period of the phase II DUET trial demonstrated the long-term nephroprotective potential and safety of sparsentan for individuals with focal segmental glomerulosclerosis (FSGS).

DUET OLE supports long-term nephroprotection of sparsentan for FSGS patients

07 Dec 2022

First-line ablation averts AF progression

07 Dec 2022 by

Among patients with paroxysmal atrial fibrillation (AF), initial treatment with cryoballoon ablation reduced the incidence of persistent AF through 3 years of follow-up compared with antiarrhythmic drug (AAD) therapy, according to the PROGRESSIVE-AF* trial presented at AHA 2022.

First-line ablation averts AF progression

07 Dec 2022

Hair zinc levels a potential biomarker for assessing psychosis risk in teens

06 Dec 2022

Lower levels of zinc in hair may be a warning signal for psychosis among treatment-naïve adolescents, a study has found.

Hair zinc levels a potential biomarker for assessing psychosis risk in teens

06 Dec 2022

Erenumab works well in chronic migraine patients across Asia

06 Dec 2022 by

Erenumab proves to be effective at lowering the number of monthly migraine days in Asian patients with chronic migraine while having a favourable safety profile, according to the results of DRAGON study.

Erenumab works well in chronic migraine patients across Asia

06 Dec 2022

News & Updates

Filter by Specialty:

Specialty:

Degarelix tied to BMD decrease in prostate cancer

Degarelix tied to BMD decrease in prostate cancer

PCSK9 inhibitors safe, effective in Asian patients, but expensive to use

PCSK9 inhibitors safe, effective in Asian patients, but expensive to use

Exposure to air pollution ups risk of atopic dermatitis

Exposure to air pollution ups risk of atopic dermatitis

Singapore’s youth endure high rates of bullying

Singapore’s youth endure high rates of bullying

Infants with lower birthweight may have poorer cardiovascular health in midlife

Infants with lower birthweight may have poorer cardiovascular health in midlife

Cyclosporin may increase malignancy risk in psoriasis

Cyclosporin may increase malignancy risk in psoriasis

DUET OLE supports long-term nephroprotection of sparsentan for FSGS patients

DUET OLE supports long-term nephroprotection of sparsentan for FSGS patients

First-line ablation averts AF progression

First-line ablation averts AF progression

Hair zinc levels a potential biomarker for assessing psychosis risk in teens

Hair zinc levels a potential biomarker for assessing psychosis risk in teens

Erenumab works well in chronic migraine patients across Asia

Erenumab works well in chronic migraine patients across Asia